Modern approaches for the investigation of natural autoantibodies to cytokines by various immunoassays

Immunologiya

Volumn 35, Issue 2, 2014, Pages 107-112

  Gavrilova, E S ^a   Tarasov, S A ^a  

^a NPF MATE RIA MEDICA HOL DING   (Russian Federation)

Author keywords

Cytokines; Methods of analysis; Natural antibodies

Indexed keywords

CYTOKINE ANTIBODY; NATURAL ANTIBODIES TO CYTOKINE; UNCLASSIFIED DRUG;

HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; REVIEW;

EID: 84990853369     PISSN: 02064952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (56)

1. Rhodes B., Vyse T.J. The genetics of SLE : an update in the light of genome-wide association studies. Rheumatology (Oxford). 2008; 47: 1603-11.
2. Munoz L.E., Lauber K., Schiller M., Manfredi A.A., Herrmann M. The role of defective clearance of apoptotic cells in systemic autoimmunity. Nature Rev. Rheumatol. 2010; 6 (5): 280-9.
3. Munoz L.E., Gaipl U.S., Franz S., Sheriff A., Voll R.E., Kalden J.R. et al. SLE-a disease of clearance deficiency? Rheumatology (Oxford). 2005; 44 (9): 1101-7.
4. Vermes I., Haanen C., Richel D.J., Schaafsma M.R., Kalsbeek-Batenburg E., Reutelingsperger C.P. Apoptosis and secondary necrosis of lymphocytes in culture. Acta Haematol. 1997; 98: 8-13.
5. Wu X., Molinaro C., Johnson N., Casiano C.A. Secondary necrosis is a source of proteolytically modified forms of specific intracellular autoantigens: implications for systemic autoimmunity. Arthr. and Rheum. 2001; 44: 2642-52.
6. Church L.D., Cook G.P., McDermott M.F. Primer: inflammasomes and interleukin 1β in inflammatory disorders. Nature Clin. Pract. Rheumatol. 2008; 4: 34-42.
7. Radic M., Marion T., Monestier M. Nucleosomes are exposed at the cell surface in apoptosis. J. Immunol. 2004; 172: 6692-700.
8. Ravichandran K.S., Lorenz U. Engulfment of apoptotic cells: signals for a good meal. Nature Rev. Immunol. 2007; 7: 964-74.
9. Gaipl U.S., Kuhn A., Sheriff A., Munoz L.E., Franz S., Voll R.E. et al. Clearance of apoptotic cells in human SLE . Curr. Dis. Autoimmun. 2006; 9: 173-87.
10. Shao W.H., Cohen P.L. Disturbances of apoptotic cell clearance in systemic lupus erythematosus. Arthr. Res. Ther. 2011; 13 (1): 202.
11. Savill J., Dransfield I., Gregory C., Haslett C. A blast from the past: clearance of apoptotic cells regulates immune responses. Nature Rev. Immunol. 2002; 2 (12): 965-75.
12. Albert M.L., Pearce S.F., Francisco L.M., Sauter B., Roy P., Silverstein R.L. et al. Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J. Exp. Med. 1998; 188: 1359-68.
13. Fransen J.H., Berden J.H., Koeter C.M., Adema G.J., Van Der Vlag J., Hilbrands L.B. Effect of administration of apoptotic blebs on disease development in lupus mice. Autoimmunity. 2012; 45 (4): 290-7.
14. Cline A.M., Radic M.Z. Apoptosis, subcellular particles and autoimmunity. Clin. Immunol. 2004; 112 (2): 175-82.
15. Decker P., Singh-Jasuja H., Haager S., Kotter I., Rammensee H.G. Nucleosome, the main autoantigen in systemic lupus erythematosus, induces direct dendritic cell activation via a MyD88-independent pathway: consequences on inflammation. J. Immunol. 2005; 174: 3326-34.
16. Tzeng T.C., Suen J.L., Chiang B.L. Dendritic cells pulsed with apoptotic cells activate self-reactive Tcells of lupus mice both in vitro and in vivo. Rheumatology (Oxford). 2006; 45: 1230-7.
17. Viorritto I.C., Nikolov N.P., Siegel R.M. Autoimmunity versus tolerance: can dying cells tip the balance? Clin. Immunol. 2007; 122 (2): 125-34.
18. Johansson U., Walther-Jallow L., Smed-Sorensen A., Spetz A.L. Triggering of dendritic cell responses after exposure to activated, but not resting, apoptotic PBMCs. J. Immunol. 2007; 179: 1711-20.
19. Bettelli E., Korn T., Kuchroo V.K. Th17: the third member of the effector T cell trilogy. Curr. Opin. Immunol. 2007; 19: 652-7.
20. Chen G.Y., Tang J., Zheng P., Liu Y. CD24 and Siglec-10 selectively repress tissue damageinduced immune responses. Science. 2009; 323: 1722-5.
21. Devitt A., Parker K.G., Ogden C.A., Oldreive C., Clay M.F., Melville L.A. et al. Persistence of apoptotic cells without autoimmune disease or inflammation in CD14-/- mice. J. Cell Biol. 2004; 167: 1161-70.
22. Stuart L.M., Takahashi K., Shi L., Savill J., Ezekowitz R.A. Mannosebinding lectin-deficient mice display defective apoptotic cell clearance but no autoimmune phenotype. J. Immunol. 2005; 174: 3220-6.
23. Bondanza A., Zimmermann V.S., Dell'Antonio G., Cin E.D., Balestrieri G., Tincani A. et al. Requirement of dying cells and environmental adjuvants for the induction of autoimmunity. Arthr. and Rheum. 2004; 50: 1549-60.
24. Gillmore J.D., Hutchinson W.L., Herbert J., Bybee A., Mitchell D.A., Hasserjian R.P. et al. Autoimmunity and glomerulonephritis in mice with targeted deletion of the serum amyloid P component gene: SAP deficiency or strain combination? Immunology. 2004; 112: 255-64.
25. Baruah P., Dumitriu I.E., Peri G., Russo V., Mantovani A., Manfredi A.A. et al. The tissue pentraxin PTX 3 limits C1q-mediated complement activation and phagocytosis of apoptotic cells by dendritic cells. J. Leukoc. Biol. 2006; 80: 87-95.
26. Manfredi A.A., Rovere-Querini P., Bottazzi B., Garlanda C., Mantovani A. Pentraxins, humoral innate immunity and tissue injury. Curr. Opin. Immunol. 2008; 20: 538-44.
27. Darrah E., Andrade F. NET s: the missing link between cell death and systemic autoimmune diseases? Front. Immunol. 2012; 3: 428.
28. Herrmann M., Voll R.E., Kalden J.R. Etiopathogenesis of systemic lupus erythematosus. Immunol. Today. 2000; 21: 424-6.
29. Baumann I., Kolowos W., Voll R.E., Manger B., Gaipl U., Neuhuber W.L. et al. Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus. Arthr. and Rheum. 2002; 46: 191-201.
30. Munoz L.E., Janko C., Grossmayer G.E., Frey B., Voll R.E., Kern P. et al. Remnants of secondarily necrotic cells fuel inflammation in systemic lupus erythematosus. Arthr. and Rheum. 2009; 60: 1733-42.
31. Tas S.W., Quartier P., Botto M., Fossati-Jimack L. Macrophages from patients with SLE and rheumatoid arthritis have defective adhesion in vitro, while only SLE macrophages have impaired uptake of apoptotic cells. Ann. Rheum. Dis. 2006; 65: 216-21.
32. Munoz L.E., Chaurio R.A., Gaipl U.S., Schett G., Kern P. MoMa from patients with systemic lupus erythematosus show altered adhesive activity. Autoimmunity. 2009; 42: 269-71.
33. Munoz L.E., Frey B., Appelt U., Janko C., Sarter K., Voll R.E. et al. Peripheral blood stem cells of patients with systemic lupus erythematosus show altered differentiation into macrophages. Open Autoimmun. J. 2010; 2: 11-6.
34. Franz S., Gaipl U., Appelt U., Heyder P., Voll R., Kalden J.R. et al. The role of a defective clearance in the pathogenesis of systemic lupus erythematosus. Arthr. Res. Ther. 2004; 6: 34.
35. Lleo A., Selmi C., Invernizzi P., Podda M., Gershwin M.E. The consequences of apoptosis in autoimmunity. J. Autoimmun. 2008; 31 (3): 257-62.
36. Cook H.T., Botto M. Mechanisms of disease: the complement system and the pathogenesis of systemic lupus erythematosus. Nature Clin. Pract. Rheumatol. 2006; 2: 330-7.
37. Lemke G., Rothlin C.V. Immunobiology of the TAM receptors. Nature Rev. Immunol. 2008; 8: 327-36.
38. Gaipl U.S., Beyer T.D., Heyder P., Kuenkele S., Böttcher A., Voll R.E. et al. Cooperation between C1q and DNase I in the clearance of necrotic cell-derived chromatin. Arthr. and Rheum. 2004; 50 (2): 640-9.
39. Kravitz M.S., Shoenfeld Y. Autoimmunity to protective molecules: is it the perpetuum mobile (vicious cycle) of autoimmune rheumatic diseases? Nature Clin. Pract. Rheumatol. 2006; 2: 481-90.
40. Shoenfeld Y., Szyper-Kravitz M., Witte T., Doria A., Tsutsumi A., Tatsuya A. et al. Autoantibodies against protective molecules - C1q, C-reactive protein, serum amyloid P, mannose-binding lectin, and apolipoprotein A1: prevalence in systemic lupus erythematosus. Ann. N. Y. Acad. Sci. 2007; 1108: 227-39.
41. Kim S.J., Gershov D., Ma X., Brot N., Elkon K.B. I-PLA(2) activation during apoptosis promotes the exposure of membrane lysophosphatidylcholine leading to binding by natural immunoglobulin M antibodies and complement activation. J. Exp. Med. 2002; 196: 655-65.
42. Quartier P., Potter P.K., Ehrenstein M.R., Walport M.J., Botto M. Predominant role of IgM-dependent activation of the classical pathway in the clearance of dying cells by murine bone marrow-derived macrophages in vitro. Eur. J. Immunol. 2004; 35: 252-60.
43. Gershov D., Kim S., Brot N., Elkon K.B. C-reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: implications for systemic autoimmunity. J. Exp. Med. 2000; 192: 1353-64.
44. Ogden C.A., de Cathelineau A., Hoffmann P.R., Bratton D., Ghebrehiwet B., Fadok V.A. et al. C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J. Exp. Med. 2001; 194: 781-95.
45. Cline A.M., Radic M.Z. Apoptosis, subcellular particles, and autoimmunity. Clin. Immunol. 2004; 112 (2): 175-82.
46. Schiller M., Bekeredjian-Ding I., Heyder P., Blank N., Ho A.D., Lorenz H.M. Autoantigens are translocated into small apoptotic bodies during early stages of apoptosis. Cell Death Differ. 2008; 15 (1): 183-91.
47. Herrmann M., Winkler T., Gaipl U., Lorenz H., Geiler T., Kalden J.R. Etiopathogenesis of systemic lupus erythematosus. Int. Arch. Allergy Immunol. 2000; 123: 28-35.
48. Kuhn A., Sonntag M., Richter-Hintz D., Oslislo C., Megahed M., Ruzicka T. et al. Phototesting in lupus erythematosus: A 15-year experience. J. Am. Acad. Dermatol. 2001; 45: 86-95.
49. Casciola-Rosen L.A., Anhalt G., Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J. Exp. Med. 1994; 179: 1317-30.
50. Rosen A., Casciola-Rosen L., Wigley F. Role of metal-catalyzed oxidation reactions in the early pathogenesis of scleroderma. Curr. Opin. Rheumatol. 1997; 9 (6): 538-43.
51. Lorenz H.M., Herrmann M., Winkler T., Gaipl U., Kalden J.R. Role of apoptosis in autoimmunity. Apoptosis. 2000; 5 (5): 443-9.
52. Cocca B.A., Cline A.M., Radic M.Z. Blebs and apoptotic bodies are B cell autoantigens. J. Immunol. 2002; 169: 159-66.
53. Gaipl U.S., Brunner J., Beyer T.D., Voll R.E., Kalden J.R., Herrmann M. Disposal of dying cells: A balancing act between infection and autoimmunity. Arthr. and Rheum. 2003; 48: 6-11.
54. Sheriff A., Gaipl U.S., Voll R.E., Kalden J.R., Herrmann M. Apoptosis and systemic lupus erythematosus. Rheum. Dis. Clin. North Am. 2004; 30: 505-27.
55. Norris D.A. Pathomechanisms of photosensitive lupus erythematosus. J. Invest. Dermatol. 1993; 100: 58-68.
56. Munoz L.E., Janko C., Schulze C., Schorn C., Sarter K., Schett G. et al. Autoimmunity and chronic inflammation - Two clearance-related steps in the etiopathogenesis of SLE . Autoimmun. Rev. 2010; 10 (1): 38-42.